FEMY — FEMASYS INC

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1339005 ·
Last close
$2.86
Market Cap
$8.64M
52W High
$10.56
52W Low
$2.64
ADV30
45,883
Next earnings

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 424,889 266,283 -4,223,533 846,100 16,495,245 5,386,041 9,205,352
Dec 2025 813,387 510,262 -4,622,728 -3,950,305 20,724,177 9,266,353 14,854,875
Sep 2025 729,394 435,556 -3,653,768 -4,194,821 16,290,153 4,569,038 11,733,902
Jun 2025 409,268 251,097 -3,851,566 -4,585,922 13,780,409 3,218,067 12,272,974

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-18,690,565
Investing CF
$-630,098
Financing CF
$25,135,255
CapEx
$-630,098
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.73
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-145,826,144
Inventory
$5,740,249
Receivables
$616,600
ST Investments
EBIT TTM
$-16,735,471
Pretax Income TTM
$-18,626,590
Interest Exp TTM
$1,891,119
Analysts
3

Yahoo Snapshot (yfinance, live)

Total Revenue
$2,376,938
EBITDA
$-16,012,144
Free Cash Flow
$-11,760,794
Enterprise Value
$7,977,822
Total Cash
$5,386,041
Total Debt
$4,727,996
Shares Out
3,019,534
Trailing EPS
$-4.80
Book Value
$2.41
ROE
-256.0%
ROA
-68.7%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 2,293,313 -17,588,669 -18,627,887 20,724,177 14,854,875 -18,690,565
Dec 2024 1,629,108 -17,785,805 -18,816,628 12,445,002 10,140,580 -19,444,009
Dec 2023 1,071,970 -14,508,415 -14,247,124 27,755,825 9,403,236 -11,280,546
Dec 2022 1,206,218 -11,600,264 -11,394,170 16,895,570 1,653,051 -10,731,973

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-5.80

Peers — same industry

TickerNameMarket CapLastDaily %
HSCS HeartSciences Inc. $8.50M $2.18
ADGM Adagio Medical Holdings, Inc. $8.40M $0.38
MBAI Check-Cap Ltd $8.19M $1.06
ICCM IceCure Medical Ltd. $9.90M $2.89
NXL Nexalin Technology, Inc. $7.44M $0.34

News headlines (Yahoo Finance, 1h cache)

Femasys Regains Compliance with Nasdaq Listing Requirements
2026-06-24 13:00 · Yahoo
Innoviva Stock Is Up Just 10% This Past Year. Here's Why a Fund Bought $2.5 Million More
2026-05-29 22:55 · Yahoo
Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter
2026-05-13 13:00 · Yahoo
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
2026-05-08 20:05 · Yahoo
Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete
2026-05-05 13:00 · Yahoo
Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026
2026-04-22 13:00 · Yahoo
Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio
2026-04-16 13:00 · Yahoo
Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth
2026-04-01 13:00 · Yahoo
Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update
2026-03-31 20:05 · Yahoo
Femasys Appoints Dr. Kenneth D. Eichenbaum to Board of Directors
2026-03-18 13:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.